Vital Signs - The New Economics of Healthcare: Evaluating Medical Technologies Based on Actual Value as a Growth Strategy for Healthcare Providers

Regular Price: USD 1,500

Special Price USD 1,050

30% OFF

* Required Fields

Regular Price: USD 1,500

Special Price USD 1,050

PAY BY INVOICE

Be the first to review this product

This issue of Vital Signs, released on October 19, 2009, provides an analysis of evaluating medical technologies based on actual value as a growth strategy for healthcare providers with the I-Flow ON-Q® Pain Relief System as a case study. Additionally, a company spotlight is provided for Cardo Medical, an emerging company focused on cutting-edge reconstructive orthopedic and spinal surgery devices that simplify and enhance surgical procedures, and improve outcomes for patients. Reimbursement and regulatory news from the FDA is also provided for the week of October 5, 2009.

Table of Contents

Vital Signs - The New Economics of Healthcare: Evaluating Medical Technologies Based on Actual Value as a Growth Strategy for Healthcare ProvidersVital Signs: 19 October 2009This week's issue:




Keyword1

Keyword2

Keyword3

Related Research

Release Date : 20-Nov-17

Region : North America

Release Date : 07-Nov-17

Region : North America

Release Date : 06-Nov-17

Region : North America

Why Frost & Sullivan

Working with the CEO’s growth team to create a vision based on a transformation growth strategy

Creating content-based digital marketing strategies that leverage our research perspective to differentiate and “tell your story”

Tracking over 1000 emerging technologies and analyzing the impact by industry and application to reveal the companies to watch in each sector

The Frost & Sullivan team is based in our 45 global offices and have developed a powerful global understandings of how industries operate on a global level.